NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

ICICI Securities Raises Target Price for Himadri Specialty Chemical

Himadri Specialty Chemical's (Himadri) fourth quarter financial results for fiscal year 2026 were a positive surprise, with the company's gross profit increasing by 28.3% year-over-year. However, the EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) performance was impacted by a foreign exchange loss of INR 0.4 billion.

Despite the Middle-East crisis, Himadri does not foresee any material impact on its operations. The company is optimistic about its future performance, with the commissioning of a newly built specialty carbon black plant expected to contribute positively to its bottom line in fiscal year 2027. Additionally, the likely commissioning of a new chemicals plant in the third quarter of fiscal year 2027 is expected to further boost the company's performance.

Himadri's balance sheet has improved significantly, with the company now holding a net cash position of INR 1 billion. This development may enable the company to invest in battery material plants without straining its leverage ratios.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Comparison of Himadri's EBITDA Estimates

Fiscal YearEBITDA Estimate (Old)EBITDA Estimate (New)Increase
FY27E-16-25% increase from old estimate-
FY28E-16-25% increase from old estimate-

ICICI Securities has revised its target price for Himadri Specialty Chemical to INR 550, a 16.8% increase from the previous target price of INR 470. The company has also revised its EV/EBITDA multiple to 15x, up from 12x. The research firm has retained its 'HOLD' recommendation for the stock.

Investor Takeaway

ICICI Securities maintains a 'Hold' rating for Himadri Speciality Chemical with a price target of Rs 550.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.